93 related articles for article (PubMed ID: 27734718)
1. Hematopoietic stem cells can be separated from leukemic cells in a subgroup of adult acute lymphoblastic leukemia patients.
Wang W; Foerner E; Buss E; Jauch A; Eckstein V; Wuchter P; Ho AD; Lutz C
Leuk Lymphoma; 2017 Jun; 58(6):1446-1454. PubMed ID: 27734718
[TBL] [Abstract][Full Text] [Related]
2. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
3. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L
PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383
[TBL] [Abstract][Full Text] [Related]
4. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
[TBL] [Abstract][Full Text] [Related]
5. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
[TBL] [Abstract][Full Text] [Related]
6. Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia.
Hoang VT; Hoffmann I; Borowski K; Zepeda-Moreno A; Ran D; Buss EC; Wuchter P; Eckstein V; Ho AD
Methods Mol Biol; 2013; 1035():217-30. PubMed ID: 23959995
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples.
Pearce DJ; Taussig D; Simpson C; Allen K; Rohatiner AZ; Lister TA; Bonnet D
Stem Cells; 2005; 23(6):752-60. PubMed ID: 15917471
[TBL] [Abstract][Full Text] [Related]
8. Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
Bogen A; Buske C; Hiddemann W; Bohlander SK; Christ O
Exp Hematol; 2017 Mar; 47():54-63. PubMed ID: 27826122
[TBL] [Abstract][Full Text] [Related]
9. Flow Cytometric Aldehyde Dehydrogenase Assay Enables a Fast and Accurate Human Umbilical Cord Blood Hematopoietic Stem Cell Assessment.
Gençer EB; Yurdakul P; Dalva K; Beksaç M
Turk J Haematol; 2017 Dec; 34(4):314-320. PubMed ID: 27956370
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC(lo) ALDH(br) cells on hematopoietic recovery.
Gündüz E; Demirel G; Bal C; Gulbas Z
Cytotherapy; 2010 Dec; 12(8):1006-12. PubMed ID: 20735165
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
[TBL] [Abstract][Full Text] [Related]
12. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors.
Venton G; Pérez-Alea M; Baier C; Fournet G; Quash G; Labiad Y; Martin G; Sanderson F; Poullin P; Suchon P; Farnault L; Nguyen C; Brunet C; Ceylan I; Costello RT
Blood Cancer J; 2016 Sep; 6(9):e469. PubMed ID: 27611922
[TBL] [Abstract][Full Text] [Related]
14. CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Kong Y; Chang YJ; Liu YR; Wang YZ; Jiang Q; Jiang H; Qin YZ; Hu Y; Lai YY; Duan CW; Hong DL; Huang XJ
Leukemia; 2014 Dec; 28(12):2398-401. PubMed ID: 25135692
[No Abstract] [Full Text] [Related]
15. Therapy response correlates with ALDH activity in ALDH low-positive childhood acute lymphoblastic leukemias.
Ahlers J; Witte KE; Schwarze CP; Lang P; Handgretinger R; Ebinger M
Pediatr Hematol Oncol; 2014 May; 31(4):303-10. PubMed ID: 24308780
[TBL] [Abstract][Full Text] [Related]
16. High proportion of CD34+/CD38-cells is positively correlated with poor prognosis in newly diagnosed childhood acute lymphoblastic leukemia.
Long J; Liu S; Li K; Zhou X; Zhang P; Zou L
Leuk Lymphoma; 2014 Mar; 55(3):611-7. PubMed ID: 23706103
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.
Lamkin T; Brooks J; Annett G; Roberts W; Weinberg K
Leukemia; 1994 Nov; 8(11):1871-8. PubMed ID: 7526089
[TBL] [Abstract][Full Text] [Related]
18. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity.
Storms RW; Trujillo AP; Springer JB; Shah L; Colvin OM; Ludeman SM; Smith C
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9118-23. PubMed ID: 10430905
[TBL] [Abstract][Full Text] [Related]
19. Expanded Hematopoietic Progenitor Cells Reselected for High Aldehyde Dehydrogenase Activity Demonstrate Islet Regenerative Functions.
Seneviratne AK; Bell GI; Sherman SE; Cooper TT; Putman DM; Hess DA
Stem Cells; 2016 Apr; 34(4):873-87. PubMed ID: 26676482
[TBL] [Abstract][Full Text] [Related]
20. Exploring the heterogeneity of the hematopoietic stem and progenitor cell pool in cord blood: simultaneous staining for side population, aldehyde dehydrogenase activity, and CD34 expression.
Frändberg S; Boreström C; Li S; Fogelstrand L; Palmqvist L
Transfusion; 2015 Jun; 55(6):1283-9. PubMed ID: 25647229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
